+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Catheters Market By Product Type: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 314 Pages
  • May 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640290
Catheters are thin tubes made up of medical grade material such as plastic, silicon rubber, PVC, and nylon inserted in the patient’s body for therapeutic and diagnostic purposes. Catheterization is a primary co-procedure along with varied other medical procedures, such as angioplasty, cardiac electrophysiology, and neurosurgery. Catheters are important components in several surgical procedures.

High prevalence of cardiovascular diseases coupled with the development of unique-feature enhanced cardiovascular catheters is the core factor that drives the growth of the catheters market. Increase in prevalence of urological diseases, including urinary bladder cancer and kidney failure has significantly uplifted the demand for urological catheters. In addition, novel products, including external male catheters have proved to be a lucrative addition to the overall catheters and variants’ product lines for the catheters manufacturing companies. Increase in patient pool for ischemic and hemorrhagic stroke thereby increased the demand for minimally invasive neurovascular surgeries, thus making way for opportunities for the neurovascular catheters-micro catheters and guiding catheters. Increase in cardiovascular diseases and growth in demand for minimal invasive surgeries drive the growth of global catheters market. In addition, rise in incidence of diabetes, cardiovascular diseases, urinary bladder, and kidney failures fuel the market growth. However, inadequate quality assurance and price competition at domestic levels are expected to hamper the market growth. In addition, the key players such as Boston Scientific Corporation, Medtronic Plc. and Teleflex Incorporated provide catheter products contributing toward the market growth. In addition, rise in demand for catheters for the drug administration act a key driving factor for expansion of the global market.

The global catheters market is segmented on the basis of type and region. Depending on the type, the market is segmented into cardiovascular catheters, neurovascular catheters, urological catheters, intravenous catheters and specialty catheters.
Cardiovascular catheter segment is classified into electrophysiology catheters, percutaneous transluminal coronary angioplasty(PTCA) balloon catheters, intravascular ultrasound(IVUS catheters), percutaneous transluminal angioplasty(PTA) catheters, and others including guiding catheter, angiography catheter, and pulmonary artery catheters. In addition, urological catheter segment is again fragmented into dialysis catheter and urinary catheter. Dialysis catheter segment is segregated into hemodialysis catheter and peritoneal catheter. Urinary catheter segment is segmented into and foley catheter, intermittent catheter, and external catheters. Furthermore, intravenous catheter segment is categorized into central intravenous catheter and peripheral intravenous catheters. Peripheral intravenous catheter segment is divided into integrated catheters and short catheters. Moreover, specialty catheter segment in classified into wound/surgical drain, oximetry, thermodilution, and IUI catheter. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the catheters market include Abbott Laboratories, Becton Dickinson And Company, Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson, Medtronic, Inc., Edwards Lifesciences Corporation, Cook Medical, and Stryker Corporation.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the catheters market analysis from 2021 to 2031 to identify the prevailing catheters market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the catheters market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global catheters market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Product Type

  • Cardiovascular Catheters
  • Neurovascular Catheters
  • Urological Catheters
  • Intravenous Catheters
  • Specialty Catheters

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Johnson and Johnson
  • Medtronic Plc
  • Edwards Lifesciences Corporation
  • Teleflex Incorporated
  • Cook Medical Inc.
  • Stryker Corporation

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: CATHETERS MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Cardiovascular Catheters
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Neurovascular Catheters
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Urological Catheters
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Intravenous Catheters
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Specialty Catheters
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
CHAPTER 5: CATHETERS MARKET, BY REGION
5.1 Overview
5.1.1 Market size and forecast
5.2 North America
5.2.1 Key trends and opportunities
5.2.2 North America Market size and forecast, by Product Type
5.2.3 North America Market size and forecast, by country
5.2.3.1 U.S.
5.2.3.1.1 Market size and forecast, by Product Type
5.2.3.2 Canada
5.2.3.2.1 Market size and forecast, by Product Type
5.2.3.3 Mexico
5.2.3.3.1 Market size and forecast, by Product Type
5.3 Europe
5.3.1 Key trends and opportunities
5.3.2 Europe Market size and forecast, by Product Type
5.3.3 Europe Market size and forecast, by country
5.3.3.1 Germany
5.3.3.1.1 Market size and forecast, by Product Type
5.3.3.2 France
5.3.3.2.1 Market size and forecast, by Product Type
5.3.3.3 U.K.
5.3.3.3.1 Market size and forecast, by Product Type
5.3.3.4 Italy
5.3.3.4.1 Market size and forecast, by Product Type
5.3.3.5 Spain
5.3.3.5.1 Market size and forecast, by Product Type
5.3.3.6 Rest of Europe
5.3.3.6.1 Market size and forecast, by Product Type
5.4 Asia-Pacific
5.4.1 Key trends and opportunities
5.4.2 Asia-Pacific Market size and forecast, by Product Type
5.4.3 Asia-Pacific Market size and forecast, by country
5.4.3.1 Japan
5.4.3.1.1 Market size and forecast, by Product Type
5.4.3.2 China
5.4.3.2.1 Market size and forecast, by Product Type
5.4.3.3 India
5.4.3.3.1 Market size and forecast, by Product Type
5.4.3.4 Australia
5.4.3.4.1 Market size and forecast, by Product Type
5.4.3.5 South Korea
5.4.3.5.1 Market size and forecast, by Product Type
5.4.3.6 Rest of Asia-Pacific
5.4.3.6.1 Market size and forecast, by Product Type
5.5 LAMEA
5.5.1 Key trends and opportunities
5.5.2 LAMEA Market size and forecast, by Product Type
5.5.3 LAMEA Market size and forecast, by country
5.5.3.1 Brazil
5.5.3.1.1 Market size and forecast, by Product Type
5.5.3.2 Saudi Arabia
5.5.3.2.1 Market size and forecast, by Product Type
5.5.3.3 South Africa
5.5.3.3.1 Market size and forecast, by Product Type
5.5.3.4 Rest of LAMEA
5.5.3.4.1 Market size and forecast, by Product Type
CHAPTER 6: COMPANY LANDSCAPE
6.1. Introduction
6.2. Top winning strategies
6.3. Product Mapping of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Key developments
CHAPTER 7: COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Product portfolio
7.1.5 Business performance
7.1.6 Key strategic moves and developments
7.2 B. Braun Melsungen AG
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Product portfolio
7.2.5 Business performance
7.2.6 Key strategic moves and developments
7.3 Becton, Dickinson and Company
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Product portfolio
7.3.5 Business performance
7.3.6 Key strategic moves and developments
7.4 Boston Scientific Corporation
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Product portfolio
7.4.5 Business performance
7.4.6 Key strategic moves and developments
7.5 Johnson and Johnson
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Product portfolio
7.5.5 Business performance
7.5.6 Key strategic moves and developments
7.6 Medtronic Plc
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Product portfolio
7.6.5 Business performance
7.6.6 Key strategic moves and developments
7.7 Edwards Lifesciences Corporation
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Product portfolio
7.7.5 Business performance
7.7.6 Key strategic moves and developments
7.8 Teleflex Incorporated
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Product portfolio
7.8.5 Business performance
7.8.6 Key strategic moves and developments
7.9 Cook Medical Inc.
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Product portfolio
7.9.5 Business performance
7.9.6 Key strategic moves and developments
7.10 Stryker Corporation
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Product portfolio
7.10.5 Business performance
7.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Catheters Market, by Product Type, 2021-2031, ($Million)
Table 2. Catheters Market Revenue, for Cardiovascular Catheters, by Region, 2021-2031, ($Million)
Table 3. Catheters Market for Cardiovascular Catheters by Country, 2021-2031, ($Million)
Table 4. Catheters Market Revenue, for Neurovascular Catheters, by Region, 2021-2031, ($Million)
Table 5. Catheters Market for Neurovascular Catheters by Country, 2021-2031, ($Million)
Table 6. Catheters Market Revenue, for Urological Catheters, by Region, 2021-2031, ($Million)
Table 7. Catheters Market for Urological Catheters by Country, 2021-2031, ($Million)
Table 8. Catheters Market Revenue, for Intravenous Catheters, by Region, 2021-2031, ($Million)
Table 9. Catheters Market for Intravenous Catheters by Country, 2021-2031, ($Million)
Table 10. Catheters Market Revenue, for Specialty Catheters, by Region, 2021-2031, ($Million)
Table 11. Catheters Market for Specialty Catheters by Country, 2021-2031, ($Million)
Table 12. Catheters Market, by Region, 2021-2031, ($Million)
Table 13. North America Catheters Market, by Product Type, 2021-2031, ($Million)
Table 14. North America Catheters Market, by Country, 2021-2031, ($Million)
Table 15. U.S. Catheters Market, by Product Type, 2021-2031, ($Million)
Table 16. Canada Catheters Market, by Product Type, 2021-2031, ($Million)
Table 17. Mexico Catheters Market, by Product Type, 2021-2031, ($Million)
Table 18. Europe Catheters Market, by Product Type, 2021-2031, ($Million)
Table 19. Europe Catheters Market, by Country, 2021-2031, ($Million)
Table 20. Germany Catheters Market, by Product Type, 2021-2031, ($Million)
Table 21. France Catheters Market, by Product Type, 2021-2031, ($Million)
Table 22. U.K. Catheters Market, by Product Type, 2021-2031, ($Million)
Table 23. Italy Catheters Market, by Product Type, 2021-2031, ($Million)
Table 24. Spain Catheters Market, by Product Type, 2021-2031, ($Million)
Table 25. Rest of Europe Catheters Market, by Product Type, 2021-2031, ($Million)
Table 26. Asia-Pacific Catheters Market, by Product Type, 2021-2031, ($Million)
Table 27. Asia-Pacific Catheters Market, by Country, 2021-2031, ($Million)
Table 28. Japan Catheters Market, by Product Type, 2021-2031, ($Million)
Table 29. China Catheters Market, by Product Type, 2021-2031, ($Million)
Table 30. India Catheters Market, by Product Type, 2021-2031, ($Million)
Table 31. Australia Catheters Market, by Product Type, 2021-2031, ($Million)
Table 32. South Korea Catheters Market, by Product Type, 2021-2031, ($Million)
Table 33. Rest of Asia-Pacific Catheters Market, by Product Type, 2021-2031, ($Million)
Table 34. LAMEA Catheters Market, by Product Type, 2021-2031, ($Million)
Table 35. LAMEA Catheters Market, by Country, 2021-2031, ($Million)
Table 36. Brazil Catheters Market, by Product Type, 2021-2031, ($Million)
Table 37. Saudi Arabia Catheters Market, by Product Type, 2021-2031, ($Million)
Table 38. South Africa Catheters Market, by Product Type, 2021-2031, ($Million)
Table 39. Rest of LAMEA Catheters Market, by Product Type, 2021-2031, ($Million)
Table 40. Abbott Laboratories: Company Snapshot
Table 41. Abbott Laboratories: Operating Segments
Table 42. Abbott Laboratories: Product Portfolio
Table 43. Abbott Laboratories: Net Sales
Table 44. Abbott Laboratories: Key Stratergies
Table 45. B. Braun Melsungen Ag: Company Snapshot
Table 46. B. Braun Melsungen Ag: Operating Segments
Table 47. B. Braun Melsungen Ag: Product Portfolio
Table 48. B. Braun Melsungen Ag: Net Sales
Table 49. B. Braun Melsungen Ag: Key Stratergies
Table 50. Becton, Dickinson and Company: Company Snapshot
Table 51. Becton, Dickinson and Company: Operating Segments
Table 52. Becton, Dickinson and Company: Product Portfolio
Table 53. Becton, Dickinson and Company: Net Sales
Table 54. Becton, Dickinson and Company: Key Stratergies
Table 55. Boston Scientific Corporation: Company Snapshot
Table 56. Boston Scientific Corporation: Operating Segments
Table 57. Boston Scientific Corporation: Product Portfolio
Table 58. Boston Scientific Corporation: Net Sales
Table 59. Boston Scientific Corporation: Key Stratergies
Table 60. Johnson and Johnson: Company Snapshot
Table 61. Johnson and Johnson: Operating Segments
Table 62. Johnson and Johnson: Product Portfolio
Table 63. Johnson and Johnson: Net Sales
Table 64. Johnson and Johnson: Key Stratergies
Table 65. Medtronic plc: Company Snapshot
Table 66. Medtronic plc: Operating Segments
Table 67. Medtronic plc: Product Portfolio
Table 68. Medtronic plc: Net Sales
Table 69. Medtronic plc: Key Stratergies
Table 70. Edwards Lifesciences Corporation: Company Snapshot
Table 71. Edwards Lifesciences Corporation: Operating Segments
Table 72. Edwards Lifesciences Corporation: Product Portfolio
Table 73. Edwards Lifesciences Corporation: Net Sales
Table 74. Edwards Lifesciences Corporation: Key Stratergies
Table 75. Teleflex Incorporated: Company Snapshot
Table 76. Teleflex Incorporated: Operating Segments
Table 77. Teleflex Incorporated: Product Portfolio
Table 78. Teleflex Incorporated: Net Sales
Table 79. Teleflex Incorporated: Key Stratergies
Table 80. Cook Medical Inc.: Company Snapshot
Table 81. Cook Medical Inc.: Operating Segments
Table 82. Cook Medical Inc.: Product Portfolio
Table 83. Cook Medical Inc.: Net Sales
Table 84. Cook Medical Inc.: Key Stratergies
Table 85. Stryker Corporation: Company Snapshot
Table 86. Stryker Corporation: Operating Segments
Table 87. Stryker Corporation: Product Portfolio
Table 88. Stryker Corporation: Net Sales
Table 89. Stryker Corporation: Key Stratergies
LIST OF FIGURES
Figure 1. Catheters Market Segmentation
Figure 2. Catheters Market, 2021-2031
Figure 3. Catheters Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Catheters Market:Drivers, Restraints and Opportunities
Figure 12. Catheters Market, by Product Type, 2021 (%)
Figure 13. Comparative Share Analysis of Cardiovascular Catheters Catheters Market, 2021-2031 (%)
Figure 14. Comparative Share Analysis of Neurovascular Catheters Catheters Market, 2021-2031 (%)
Figure 15. Comparative Share Analysis of Urological Catheters Catheters Market, 2021-2031 (%)
Figure 16. Comparative Share Analysis of Intravenous Catheters Catheters Market, 2021-2031 (%)
Figure 17. Comparative Share Analysis of Specialty Catheters Catheters Market, 2021-2031 (%)
Figure 18. Catheters Market by Region, 2021
Figure 19. U.S. Catheters Market, 2021-2031 ($Million)
Figure 20. Canada Catheters Market, 2021-2031 ($Million)
Figure 21. Mexico Catheters Market, 2021-2031 ($Million)
Figure 22. Germany Catheters Market, 2021-2031 ($Million)
Figure 23. France Catheters Market, 2021-2031 ($Million)
Figure 24. U.K. Catheters Market, 2021-2031 ($Million)
Figure 25. Italy Catheters Market, 2021-2031 ($Million)
Figure 26. Spain Catheters Market, 2021-2031 ($Million)
Figure 27. Rest of Europe Catheters Market, 2021-2031 ($Million)
Figure 28. Japan Catheters Market, 2021-2031 ($Million)
Figure 29. China Catheters Market, 2021-2031 ($Million)
Figure 30. India Catheters Market, 2021-2031 ($Million)
Figure 31. Australia Catheters Market, 2021-2031 ($Million)
Figure 32. South Korea Catheters Market, 2021-2031 ($Million)
Figure 33. Rest of Asia-Pacific Catheters Market, 2021-2031 ($Million)
Figure 34. Brazil Catheters Market, 2021-2031 ($Million)
Figure 35. Saudi Arabia Catheters Market, 2021-2031 ($Million)
Figure 36. South Africa Catheters Market, 2021-2031 ($Million)
Figure 37. Rest of LAMEA Catheters Market, 2021-2031 ($Million)
Figure 38. Top Winning Strategies, by Year
Figure 39. Top Winning Strategies, by Development
Figure 40. Top Winning Strategies, by Company
Figure 41. Product Mapping of Top 10 Players
Figure 42. Competitive Dashboard
Figure 43. Competitive Heatmap of Top 10 Key Players
Figure 44. Abbott Laboratories.: Net Sales, ($Million)
Figure 45. B. Braun Melsungen AG.: Net Sales, ($Million)
Figure 46. Becton, Dickinson and Company.: Net Sales, ($Million)
Figure 47. Boston Scientific Corporation.: Net Sales, ($Million)
Figure 48. Johnson and Johnson.: Net Sales, ($Million)
Figure 49. Medtronic PLC.: Net Sales, ($Million)
Figure 50. Edwards Lifesciences Corporation.: Net Sales, ($Million)
Figure 51. Teleflex Incorporated.: Net Sales, ($Million)
Figure 52. Cook Medical Inc. Net Sales, ($Million)
Figure 53. Stryker Corporation.: Net Sales, ($Million)

Executive Summary

According to this report titled, 'Catheters Market,' the catheters market was valued at $22.7 billion in 2021, and is estimated to reach $49.5 billion by 2031, growing at a CAGR of 8.1% from 2022 to 2031.

Catheter is a thin tube which is made from medical grade materials. They are medical devices that can be inserted in the body to treat diseases or perform a surgical procedure. The scope catheters has widened, as it is used to treat various neurological, cardiovascular, and urological disorders with the help of improved clinical practices and advanced technologies. Diagnosis, prevention, and treatment are the prime focus of healthcare departments across all the regions. Catheterization is a basic co-procedure along with various medical procedures that includes cardiac electrophysiology, neurosurgery, angioplasty, urological disorders, and specialty catheters; catheters being a key component in the above procedures. Hence, using ancillary medical devices such as catheters are used to treat diseases making it a lucrative market across the globe.

Rise in case of cardiovascular & urological diseases and diabetes and growth in demand for minimally invasive procedures are some catheters market trends which boost the growth of the catheters market. Furthermore, technologically advanced catheters are manufactured with infection resistant coating to minimize catheter-associated infections. Thus, these are preferred by customers (healthcare professionals), which leads to the growth of the catheter market. Reimbursement plays a vital role to raise the utilization rate of catheters. Increase in reimbursement levels from 4 to 200 catheters per patient per month by Medicare and Medicaid systems in the U.S. particularly for the intermittent catheters (a type of urological catheters) contributes to the increase in the utilization rates of such catheters in all healthcare set-ups. However, price competition in domestic/local markets and inadequate quality assurance hamper the growth of the catheters market.
In addition, the prevalence of cardiovascular diseases in China has been increasing continuously. As per the report published in the Journal of Geriatric Cardiology by Li-Yuan Ma, in China, in 2020, over 290 million individuals suffered from cardiovascular diseases and nearly 2 out of every 5 fatalities occurred as a result of cardiovascular diseases(CVD). Therefore, rise in number of cardiovascular diseases results in increase in number of surgeries. This has led to increase in usage of catheters for the diagnosis that boosts the growth of the market.

Moreover, development of pharmaceutical & medical device industries and improvement in healthcare spending are some factors for catheters market growth. In addition, increase in demand for performing surgeries led to development of innovative instruments in the healthcare sector, thereby propelling the growth of the market.
Depending on product, the market is segmented into cardiovascular catheters, neurovascular catheters, urological catheters, intravenous catheters, and specialty catheters. Cardiovascular catheter segment is classified into its subtypes such as electrophysiology catheters, percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, intravascular ultrasound (IVUS catheters), percutaneous transluminal angioplasty (PTA) catheters, and others include guiding catheter, angiography catheter, and pulmonary artery catheters. According to urological catheter segment the market is fragmented into dialysis catheter and urinary catheter. As per intravenous catheter segment it is categorized into central intravenous catheter and peripheral intravenous catheters. Furthermore, specialty catheter segment is classified wound/surgical drain, oximetry, thermodilution, and intrauterine insemination(IUI) catheters.

The cardiovascular catheters segment market holds the highest share in overall catheters market. Owing to the facts stated as the rise in cardiovascular diseases that necessitate the use of catheters in diagnostic as well as surgical cardiac procedures, renders highest growth of this segment.
Urological catheters depict high market attractiveness in catheters industry, owing to low prices, favorable reimbursement rates, and high volumes resulting from high utilization rates due to rise in incidences of urinary tract infections (UTI) and increase in proportion of geriatric population (that typically display high incidence of urological diseases). Similar to the cardiovascular catheters, high growth of the urological catheters market is also been observed by the development of technologically advanced catheters and increase in reimbursement rates for intermittent catheters. Technologically advanced catheters are manufactured with 'infection resistant coating” technology. For instance, Bard Medical has developed anti-infective latex Foley catheters, The BARDEX I.C., which minimizes the urinary tract infection (UTI) to a large extent-therefore are increasingly preferred by customers (healthcare professionals).

By region, North America and Asia-Pacific are the most lucrative market segments. The growth of these markets is mainly due to rise in geriatric population and increase in incidence & prevalence of cardiovascular & urological diseases.
In North America, the U.S. has garnered a dominant Catheters Market share, due to the technological advancements, stringent government regulations, rise in incidences of healthcare associated infections (HAI), and increase in awareness among the patients and the caregivers of the markets. Asia-Pacific catheters market ranks second to the North American catheters market. In Asia-Pacific, key countries include India, Japan, China, and Australia. Of the stated, China and India collectively constitute large patient-bases of cardiovascular, urological, and other diseases, which boost the growth of the market.
In addition, increase in healthcare expenditure, improvement in healthcare infrastructure, and growth in medical tourism fuel the growth of the catheters market size.
Some of the leading companies profiled in this report include, Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Johnson & Johnson, Medtronic Inc., Edward Life Sciences, Cook Medical, Teleflex Incorporated and Stryker Corporation.

KEY FINDINGS OF THE STUDY

  • By type, the cardiovascular catheters segment was the highest contributor to the market in 2021.
  • North America accounted for a majority of the catheter market share in 2021, and is anticipated to remain dominant during the forecast period.

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Johnson and Johnson
  • Medtronic Plc
  • Edwards Lifesciences Corporation
  • Teleflex Incorporated
  • Cook Medical Inc.
  • Stryker Corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...